A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine

AIDS Patient Care and STDs

Volumn 26, Issue 11, 2012, Pages 681-693

  Mimiaga, Matthew J ^a,b,c   Reisner, Sari L ^b,c   Pantalone, David W ^c,d   O'Cleirigh, Conall ^a,c   Mayer, Kenneth H ^c,e   Safren, Steven A ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c FENWAY INSTITUTE   (United States)

^d UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; BEHAVIORAL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG ABUSE; ENZYME IMMUNOASSAY; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; MALE HOMOSEXUAL; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTIPLE DRUG ABUSE; OUTCOMES RESEARCH; PATIENT COUNSELING; PILOT STUDY; RISK REDUCTION; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CONFIDENCE INTERVALS; DEPRESSION; DRUG USERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; PILOT PROJECTS; RISK REDUCTION BEHAVIOR; SAFE SEX; SEX COUNSELING; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 84868621537     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0216     Document Type: Article

References (91)

1. Centers for Disease Control and Prevention (CDC). HIV and AIDS among Gay and Bisexual Men. Atlanta, GA: U.S. Department of Health and Human Services, 2010.
2. Centers for Disease Control and Prevention (CDC). Subpopulations estimates from the HIV incidence surveillance system-United States, 2006, 2008.
3. Centers for Disease Control and Prevention (CDC).HIV Surveillance in Men Who Have Sex with Men (MSM). www.cdc.gov/hiv/topics/surveillance/resources/ slides/ msm/slides/msm.pdf (Last accessed September 5, 2012).
4. Centers for Disease Control and Prevention (CDC). Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2009 Atlanta, GA: U.S. Department of Health and Human Services, 2009.
5. Mimiaga MJ, Fair AD, Mayer KH, et al. Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use. AIDS Educ Prev 2008;20:30-41. (Pubitemid 351481856)
6. Halkitis PN, Parsons JT, Stirratt MA. A double epidemic: Crystal methamphetamine use and its relation to HIV prevention among gay men. J Homosex 2001;41:17-35. (Pubitemid 32995762)
7. Mansergh G, Colfax G, Marks G, et al. The Circuit Party Men's Health Survey: Findings and implications for gay and bisexual men. Am J Public Health 2001;91:953-958. (Pubitemid 32496740)
8. Mattison AM, Ross MW, Wolfson T, Franklin D, Group H. Circuit party attendance, club drug use, and unsafe sex in gay men. J Subst Abuse 2001;13:119-126. (Pubitemid 38209965)
9. Woody GE, VanEtten-Lee ML, McKirnan D, et al. Substance use among men who have sex with men: Comparison with a national household survey. J Acquire Immune Defic Syndrome 2001;27:86-90. (Pubitemid 32587246)
10. Rajasingham R, Mimiaga MJ, White JM, et al. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDs 2012;26:36-52.
11. VanDevanter N, Duncan A, Burrell-Piggott T, et al. The influence of substance use, social sexual environment, psychosocial factors, and partner characteristics on high-risk sexual behavior among young Black and Latino men who have sex with men living with HIV: A qualitative study. AIDS Patient Care STDs 2011;25:113-121.
12. Mimiaga MJ, Reisner SL, Bland S, et al. "It's a quick way to get what you want": A formative exploration of HIV risk among urban Massachusetts men who have sex with men who attend sex parties. AIDS Patient Care STDs 2010;24: 659-674.
13. Colfax G, Shoptaw S. The methamphetamine epidemic: Implications for HIV prevention and treatment. Curr HIV/ AIDS Rep 2005;2:194-199.
14. Fernandez MI, Bowen GS, Varga LM, et al. High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida. Subst Use Misuse 2005;40:1347-1362.
15. Morgenstern J, Bux DA, Jr., Parsons J, et al. Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men. J Consult Clin Psychol 2009; 77:645-656.
16. Shoptaw S, Frosch D. Substance abuse treatment as HIV prevention for men who have sex with men. AIDS Behav 2000;4:193-203. (Pubitemid 30421776)
17. Stall R, Purcell DW. Intertwining epidemics: A review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS Behav 2000;4:181-192. (Pubitemid 30421775)
18. Substance Abuse and Mental Health Services Administration (SAMHSA). Summary of Findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies, 2001.
19. Chesney M, Koblin B, Barresi P, et al. An individually tailored intervention for HIV prevention: Baseline data from the EXPLORE study. Am J Public Health 2003;93:933-938. (Pubitemid 38480225)
20. Koblin B, Chesney M, Husnik M, et al. High-risk behaviors among men who have sex With men in 6 US cities: Baseline data from the EXPLORE study. Am J Public Health 2003;93:926-932. (Pubitemid 38480224)
21. Colfax G, Vittinghoff E, Husnik MJ, et al. Substance use and sexual risk: A participant-and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 2004;159:002-1012.
22. Halkitis PN, Parsons JT, Wilton L. An exploratory study of contextual and situational factors related to methamphetamine use among gay and bisexual men in New York City. J Drug Issues 2003;3:415-434.
23. National Institute on Drug Abuse (NIDA). Methamphetamine Abuse and Addiction, 2006.
24. Office of National Drug Control Policy. Methamphetamine Trends in the United States, 2010.
25. Buchacz K, McFarland W, Kellogg TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19: 1423-1424. (Pubitemid 41800679)
26. Celentano DD, Valleroy LA, Sifakis F, et al. Associations between substance use and sexual risk among very young men who have sex with men. Sex Transm Dis 2006;33: 265-271.
27. Frosch D, Shoptaw S, Huber A, Rawson RA, Ling W. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 1996;13:483-486. (Pubitemid 27264294)
28. Halkitis P, Shrem M, Martin F. Sexual behavior patterns of methamphetamine-using gay and bisexual men. Subst Use Misuse 2005;40:703-719. (Pubitemid 40594399)
29. Halkitis PN, Green K, Carragher D. Methamphetamine use, sexual behavior and HIV seroconversion. J Gay Lesbian Psychother 2006;10:95-109. (Pubitemid 44275757)
30. Halkitis PN, Moeller RW, Siconolfi DE, et al. Methamphetamine and poly-substance use among gym-attending men who have sex with men in New York City. Ann Behav Med 2008;35:41-48.
31. Halkitis PN, Mukherjee PP, Palamar JJ. Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav 2009;13: 783-791.
32. Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquire Immune Defic Syndrome 2007;45:85-92. (Pubitemid 46684447)
33. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: The Urban Men's Health Study. Addiction 2001;96:1589-1601.
34. Peck JA, Shoptaw S, Rotheram-Fuller E, Reback CJ, Bierman B. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetaminedependent men who have sex with men. J Addict Dis 2005;24:115-132. (Pubitemid 41542399)
35. Shoptaw S, Reback CJ, Peck JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIVrelated sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005;78:125-134. (Pubitemid 40544599)
36. Hopko DR, Lejuez CW, Hopko SD. Behavioral activation as an intervention for co-existent depressive and anxiety symptoms. Clin Case Stud 2004;3:37-48.
37. Hopko DR, Lejuez CW, Lepage JP, Hopko SD, McNeil DW. A brief behavioral activation treatment for depression: A randomized pilot trial within an inpatient psychiatric hospital. Behav Modif 2003;27:458-469.
38. Hopko DR, Lejuez CW, Ruggiero KJ, Eifert GH. Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. Clin Psychol Rev 2003; 23:699-717. (Pubitemid 37100984)
39. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Belmont, CA: Wadsworth Publishing, 2002.
40. Fisher JD, Fisher WA. Changing AIDS risk behavior. Psychol Bull 1992;111:455-474.
41. Fisher W, Fisher JD. A general social psychological model for changing AIDS risk behavior. In: Pryor JR, ed. The Social Psychology of HIV Infection. Hillsdale, NJ: Erlbaum, 1993: 127-153.
42. Safren S, Otto M, Worth J. Life-Steps: Applying cognitivebehavioral therapy to patient adherence to HIV medication treatment. Cogn Behav Pract 1999;6:332-341.
43. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press, 1991.
44. D'Zurilla TJ. Problem-Solving Therapy: A Social Competence Approach to Clinical Intervention. New York: Springer, 1986.
45. Nezu AM, Nezu CM, Perri MG. Problem-Solving Therapy for Depression: Theory, Research, and Clinical Guidelines. New York: Wiley, 1989.
46. D'Zurilla TJ, Nezu AM. Problem-Solving Therapy: A Social Competence Approach to Clinical Intervention, 2nd ed. New York: Springer Publishing, 1999.
47. Addis ME, Martell CR. Overcoming Depression One Step at a Time. Oakland, CA: New Harbinger Publications, 2004.
48. McLellan AT, Luborski LO, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 1980;168:26-33. (Pubitemid 10187569)
49. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992;9: 199-213.
50. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. B J Psychiatry 1979;134: 382-389. (Pubitemid 9136500)
51. Kanter JW, Mulick P, Martell C. The Behavioral Activation Scale. Milwaukee, WI: University of Wisconsin-Milwaukee, 2004.
52. Jacobson NS, Martell CR, Dimidjian S. Behavioral activation therapy for depression: Returning to contextual roots. Clin Psychol Sci Pract 2001;8:255-270. (Pubitemid 33681910)
53. Martell C. Behavioral activation therapy for depression. In: O'Donohue WF, Hayes J, eds. Cognitive Behavior Therapy: Applying Empirically Supported Techniques New York: John Wiley & Sons, 2003:28-32.
54. Martell CR, Addis ME. Behavioral activation as a contextual treatment for depression. Annual Meeting of the Association for the Advancement of Behavior Therapy. Philadelphia, PA: 2001.
55. Martell CR, Addis ME. Behavioral activation as a contextual treatment for depression. Annual Meeting of the Association for the Advancement of Behavior Therapy. Reno, NV: 2002.
56. Martell CR, Addis ME, Dimidjian S. Finding the action in behavioral activation: The search for empirically-supported interventions and mechanisms of change. In: Hayes SL, Golette MV, eds. Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition New York: Guilford, 2004: 152-167.
57. Martell CR, Addis ME, Jacobson NS. Depression in Context: Strategies for Guided Action. New York: W.W. Norton & Company, Inc, 2001.
58. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care 2005;17:661-673. (Pubitemid 41113004)
59. Bryan AD, Fisher DJ, Benziger TJ. Determinants of HIV risk among Indian truck drivers. Soc Sci Med 2001;53:1413-1426. (Pubitemid 32916317)
60. Starace F, Massa A, Amico KR, Fisher JD. Adherence to antiretroviral therapy: An empirical test of the informationmotivation-behavioral skills model. Health Psychol 2006;25: 53-162.
61. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons, 2004.
62. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press, 2003.
63. Carroll KM. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Exp Clin Psychopharmacol 1996;4:46-54. (Pubitemid 26077293)
64. Carroll KM. Implications of recent research for program quality in cocaine dependence treatment. Subst Use Misuse 2002;35:2011-2030. (Pubitemid 32004735)
65. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multisite comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004;99: 708-717. (Pubitemid 38747908)
66. Rawson RA, McCann MJ, Flammino F, et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006;101:267-274. (Pubitemid 43351600)
67. Higgins S, Budney A, Bickel W, et al. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993;150:763-769. (Pubitemid 23137683)
68. Higgins ST, Heil SH, Lussier JP. Clinical implications of reinforcement as a determinant of substance use disorders. Ann Rev Psychol 2004;55:431-461.
69. Higgins ST, Wong CJ, Badger GJ, Ogden DEH, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol 2000;68:64-72. (Pubitemid 30120951)
70. Shoptaw S, Heinzerling KG, Rotheram-Fuller E, et al. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 2008;96:222-232.
71. Shoptaw S, Huber A, Peck J, et al. Randomized, placebocontrolled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006;85:12-18. (Pubitemid 44321939)
72. Roll JM, Petry NM, Stitzer ML, et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006;163:1993-1999. (Pubitemid 44807792)
73. Vocci FJ, Montoya ID. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry 2009;22:263-268.
74. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006;101:192-203. (Pubitemid 43351594)
75. Petry NM, Alessi SM, Marx J, Austin M, Tardif M. Vouchers versus prizes: Contingency management treatment of substance abusers in community settings. J Consult Clin Psychol 2005;73:1005-1014. (Pubitemid 43161099)
76. Malow RM, West JA, Corrigan SA, Pena JM, Cunningham SC. Outcome of psychoeducation for HIV risk reduction. AIDS Educ Prev 1994;6:113-125. (Pubitemid 24113412)
77. Stall RD, Paul JP, Barrett DC, Crosby GM, Bein E. An outcome evaluation to measure changes in sexual risk-taking among gay men undergoing substance use disorder treatment. J Stud Alcohol 1999;60:837-845. (Pubitemid 29526550)
78. National Institute on Drug Abuse (NIDA).NIDA InfoFacts: Methamphetamine. www.drugabuse.gov/pdf/infofacts/ Methamphetamine09.pdf (Last accessed July 16, 2009).
79. Vocci FJ, Appel NM. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 2007;102:96-106. (Pubitemid 46328210)
80. Elkashef AM, Rawson RA, Anderson AL, et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 2007;33:1162-1170. (Pubitemid 351367539)
81. Heinzerling KG, Shoptaw S, Peck JA, et al. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006;85:177-184. (Pubitemid 44666282)
82. Rothman RB, Baumann MH. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann NY Acad Sci 2006;1074: 245-260. (Pubitemid 44532828)
83. Rothman RB, Blough BE, Baumann MH. Dual dopamine/ serotonin releasers: Potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol. 2008;16:458-474.
84. Rothman RB, Blough BE, Baumann MH. Dopamine/ serotonin releasers as medications for stimulant addictions. In: Giuseppe Di Giovann VDM, Ennio E, eds. Progress in Brain Research, Vol. 172. Philadelphia, PA: Elsevier, 2008: 385-406.
85. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry 2005;13:141-154. (Pubitemid 40967247)
86. Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W. Methamphetamine abstinence syndrome: Preliminary findings. Am J Addict 2004;13:248-255. (Pubitemid 38886472)
87. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004;13: 181-190. (Pubitemid 38585698)
88. Kurtz S. Post-circuit blues: Motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav 2005;9:63-72. (Pubitemid 40575665)
89. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV positive men who have sex with men. J Subst Abuse Treat 2002;22: 149-156. (Pubitemid 34597219)
90. Jaffe A, Shoptaw S, Stein J, Reback CJ, Rotheram-Fuller E. Depression ratings, reported sexual risk behaviors, and methamphetamine use: Latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol 2007; 15:301-307. (Pubitemid 47445258)
91. Safren SA, Reisner SL, Herrick A, Mimiaga MJ, Stall RD. Mental health and HIV risk in men who have sex with men. J Acquir Immune Defic Syndrome 2010;55:S74-S77.